
Bristol-Myers, Pfizer slash Eliquis price for cash-paying patients
In a direct-to-patient move likely to reverberate across the pharmaceutical landscape, Bristol-Myers Squibb and Pfizer announced today they will begin offering their blockbuster blood thinner Eliquis at a discount to U.S. patients who pay out of pocket — …